ROC curve was used to evaluate the value of albumin on the therapeutic outcomes of patients with CHF, which indicated 37.5g/L was the optimal cut-off point for albumin to predict the therapeutic outcomes of patient with CHF. Here, ALB is linked to congestive heart failure.